Immunization with amyloidbeta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, vol.400, pp.173-177, 1999. ,
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, Nature, vol.408, pp.979-982, 2000. ,
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease, Nature, vol.408, pp.982-985, 2000. ,
Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report, Nat. Med, vol.9, pp.448-452, 2003. ,
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease, Brain Pathol, vol.14, pp.11-20, 2004. ,
Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden, Ann. Neurol, vol.65, pp.24-31, 2009. ,
Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS, Neurobiol. Dis, vol.34, pp.63-70, 2009. ,
Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice, Neurobiol. Dis, vol.23, pp.351-361, 2006. ,
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease, J. Clin. Invest, vol.112, pp.415-422, 2003. ,
HLA-DR alleles in amyloid betapeptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele, J. Immunol, vol.183, pp.3522-3530, 2009. ,
Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. USA, vol.103, pp.5048-5053, 2006. ,
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology, EMBO Rep, vol.7, pp.940-946, 2006. ,
Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid, Int. Immunol, vol.15, pp.505-514, 2003. ,
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide, J. Immunol, vol.174, pp.1580-1586, 2005. ,
Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice, Vaccine, vol.24, pp.4630-4639, 2006. ,
Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration, J. Neuroimmunol, vol.188, pp.117-127, 2007. ,
Increased T regulatory cells lead to development of Th2 immune response in male SJL mice, Autoimmunity, vol.44, pp.219-228, 2011. ,
BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD252 responder T cells than C57BL/6 mice, J. Leukoc. Biol, vol.78, pp.114-121, 2005. ,
A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes, Immunogenetics, vol.55, pp.149-156, 2003. ,
Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study, Lupus, vol.20, pp.137-143, 2011. ,
Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients, J. Dermatol. Sci, vol.57, pp.51-56, 2010. ,
The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts, J. Autoimmun, vol.28, pp.201-207, 2007. ,
Analysis of the Foxp3/scurfin gene in Crohn's disease, Ann. N. Y. Acad. Sci, vol.1051, pp.218-228, 2005. ,
Cerebral hemorrhage after passive antiAbeta immunotherapy, Science, vol.298, p.1379, 2002. ,
Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice, Proc. Natl. Acad. Sci. USA, vol.106, pp.4501-4506, 2009. ,
,
, A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease, Clinical Trial Investigators, vol.73, pp.2061-2070, 2009.
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, Lancet, vol.372, pp.216-223, 2008. ,
Systemic inflammatory cells fight off neurodegenerative disease, Nat. Rev. Neurol, vol.6, pp.405-410, 2010. ,
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1, Proc. Natl. Acad. Sci. USA, vol.103, pp.11784-11789, 2006. ,
T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease, PLoS ONE, vol.5, p.10830, 2010. ,
Dual effect of CD4+ CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia, Proc. Natl. Acad. Sci. USA, vol.101, pp.14663-14669, 2004. ,